New Delhi: Foreign-made COVID-19 vaccines such as those manufactured by Pfizer and Moderna on Wednesday moved a step closer to being approved for emergency usage in India. The Drugs Controller General of India has now done away with the requirement of local bridging trials for foreign vaccines that have already been approved by certain other health bodies and governments. As per the earlier requirements, vaccines that had undertaken clinical studies outside of India were required to hold a local trial.